Indication

Prevention of uterine inertia

Uterine inertia, also referred to as hypotonic uterine dysfunction or uterine atony during labor, is an obstetric complication characterized by inadequate, infrequent, or uncoordinated myometrial contractions during childbirth. Read more about Prevention of uterine inertia

15 drugs 14 manufacturers

Advertisement

Drugs that treat it

Common Prevention of uterine inertia therapies.

Showing 10–15 of 15 drugs

Filter & compare in the drug finder →Opens the drug finder with Prevention of uterine inertia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Prevention of uterine inertia.

Uterine inertia, also referred to as hypotonic uterine dysfunction or uterine atony during labor, is an obstetric complication characterized by inadequate, infrequent, or uncoordinated myometrial contractions during childbirth.

Affecting parturient females during the first, second, or third stages of labor, this condition impairs effective cervical dilation, fetal descent, or post-delivery uterine involution.

Prevention of uterine inertia focuses on averting this expulsive dysfunction to reduce the risks of protracted labor, obstructed delivery, and life-threatening postpartum hemorrhage caused by uterine smooth muscle exhaustion or failure to contract.

Personalize your experience

Follow Prevention of uterine inertia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it